Latest News about AZN
Recent news which mentions AZN
Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28
November 28, 2022
From Benzinga
AstraZeneca Bets On UK Listed Firm For Lung Diseases
November 28, 2022
From Benzinga
From Benzinga
2 Breakout Growth Stocks to Buy for the Long Haul
November 19, 2022
From Motley Fool
2 Stocks to Buy Whether or Not a Recession Is Coming
November 18, 2022
From Motley Fool
Why Shares of Compugen Jumped 17.86% on Thursday
November 17, 2022
From Motley Fool
How Long Can This Top Stock Continue Defying the Bear Market?
November 17, 2022
From Motley Fool
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
November 14, 2022
From Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
From Benzinga
From Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
AstraZeneca PLC (AZN) Q3 2022 Earnings Call Transcript
November 10, 2022
Tickers
AZN
From Motley Fool
From Benzinga
From Benzinga
Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks
November 10, 2022
From Motley Fool
AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength
November 10, 2022
From Benzinga
AstraZeneca lifts guidance after forecast-beating profit and sales
November 10, 2022
Tickers
AZN
From MarketWatch
From Benzinga
FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids
November 09, 2022
From Benzinga
Options Traders Expect AstraZeneca Shares To Fall After Earnings Report, As Stock Is Up 5% In 2022
November 09, 2022
Tickers
AZN
From Benzinga
Why Are Apellis Pharmaceuticals Shares Falling Today?
November 04, 2022
From Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
From Benzinga
Why Horizon Therapeutics' Shares Rose 11.32% on Wednesday
November 02, 2022
From Motley Fool
Sorrento Has Potential To Deliver Multiple Best-In-Class Products
November 02, 2022
From Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
November 01, 2022
From InvestorPlace
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.